Glucose Baxter (Glucose Monohydrate)

Glucose Baxter is indicated for several clinical situations where rapid glucose delivery or fluid support is required.

• Treatment of acute hypoglycemia to quickly raise blood glucose levels.
• Fluid and electrolyte replacement in patients unable to tolerate oral intake.
• Caloric support as part of parenteral nutrition regimens.
• Dilution and carrier solution for compatible intravenous medications.
• Intraoperative glucose supplementation during surgical procedures.
• Maintenance of blood glucose homeostasis during critical care monitoring.
• Provision of isotonic solution to assist with volume resuscitation when combined with electrolytes.

Adverse reactions to Glucose Baxter are generally related to the intravenous administration of a glucose solution and may vary in frequency. These events are typically dose‑related and resolve after discontinuation or appropriate management.

Common

• Mild hyperglycemia with transient elevation of blood glucose.
• Local irritation or pain at the infusion site.
• Nausea or vomiting if administered rapidly.
• Electrolyte shifts such as mild hyponatremia.
• Transient headache associated with rapid infusion rates.
• Mild metabolic acidosis in patients with impaired renal function.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reactions including rash, urticaria, or anaphylaxis.
• Fluid overload causing pulmonary edema in susceptible patients.

When using Glucose Baxter, clinicians should observe specific precautions to minimize risks and ensure safe administration.

• Verify patient’s blood glucose level before infusion to avoid overtreatment.
• Adjust infusion rate in patients with cardiac or renal insufficiency.
• Monitor fluid balance and signs of overload, especially in critically ill patients.
• Use aseptic technique to prevent contamination of the intravenous solution.
• Check compatibility with other IV drugs; avoid mixing with solutions containing calcium or phosphate.
• Document any adverse reactions promptly in the patient’s medical record.

Glucose Baxter may interact with certain intravenous agents or conditions; awareness of these interactions helps prevent complications.

Avoid

• Co‑administration with high‑dose insulin infusions without glucose monitoring.
• Mixing with calcium‑containing solutions that can precipitate calcium gluconate.
• Concurrent use with hyperosmolar agents that increase risk of fluid overload.
• Avoid rapid bolus administration in patients with compromised blood‑brain barrier.

Use with caution

• Concurrent administration of diuretics; monitor electrolyte balance closely.
• Use in patients receiving total parenteral nutrition; adjust carbohydrate calculations.
• Administration alongside beta‑adrenergic agonists; observe for exaggerated hyperglycemic response.